Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P100042/S039

Aptima HPV Assay 250T (Panther) Box 1; Aptima HPV Assay 250T (Panther) Box 2; Aptima HPV Assay Calibrators; Aptima HPV A

Gen-Probe Incorporated · Decision date Oct 7, 2025

FDA DECISIONP100042/S039

What did the FDA decide?

FDA records P100042/S039 as a supplement to PMA P100042, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 7, 2025.

FDA approval order statement

to adjust raw material test method
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Microbiology
Decision date
Oct 7, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P100042/S039
Regulatory pathway
PMA supplement
Product code
OYB
Decision code
OK30
Decision date
Oct 7, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Kit, rna detection, human papillomavirus.

Product code
OYB
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P100042/S039 received

    Application receipt date recorded by FDA.

  2. P100042/S039 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P100042. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P100042

Product / regulatory recordCompanyPathwayDecision dateSource
APTIMA HPV ASSAYP100042/S038
Gen-Probe IncorporatedPMA supplementFeb 3, 2026FDA

Explore the linked device profile

Other records with product code OYB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Gen-Probe Incorporated

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10210 Genetic Center Dr., San Diego, CA, 92121

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records